Post#4828 Looks like Fresenius is trying to make a move in Aethlon's space. If they succeed, a buy-out of Aethlon by Baxter would be the next logical move in the competition between these two dialysis companies. I for one believe they maybe infringing on Aethlon's IP, but that remains to be seen as it was requested for examination in April of 2013 with results still pending. Something for the y'all to chew on...